First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.81 EUR 0.72% Market Closed
Updated: Apr 25, 2024

BRAIN Biotech AG
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Operating Income Peer Comparison

Comparables:
WCH
EVK
1COV
ACT
SY1

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Operating Income
-€5.7m
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Operating Income
€364.6m
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
9%
Evonik Industries AG
XETRA:EVK
Operating Income
€1.3B
CAGR 3-Years
18%
CAGR 5-Years
1%
CAGR 10-Years
0%
Covestro AG
XETRA:1COV
Operating Income
€153m
CAGR 3-Years
-41%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Operating Income
€57.1m
CAGR 3-Years
21%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Operating Income
€550.1m
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
8%

See Also

What is BRAIN Biotech AG's Operating Income?
Operating Income
-5.7m EUR

Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Operating Income amounts to -5.7m EUR.

What is BRAIN Biotech AG's Operating Income growth rate?
Operating Income CAGR 5Y
11%

Over the last year, the Operating Income growth was -7%. The average annual Operating Income growth rates for BRAIN Biotech AG have been 16% over the past three years , 11% over the past five years .